Ironwood Pharmaceuticals, Inc. (IRWD) - NASDAQ
  • freefdawatchlist | Send Message 8 May After hour earnings for May 9th: $HALO, $HTZ, $INVN, $IRWD, $OAS, $OPK, $PAH, $RAX, $SCTY, $STMP, $SEDG
      • Phase Five Research | Send Message 27 Apr

        Uncovered: Safety Issues Linked With Ironwood's Drug, Linzess $IRWD
          • freefdawatchlist | Send Message 27 Apr

   Most Volatile stocks: $ORIG, $SEED, $UNXL, $BCRX, $IRWD
              • hikeleader | Send Message 26 Apr

                $SGYP - Tough report out on $IRWD Linzess:
                Reply (1)
                • Vina1234 | Send Message 27 Apr
                  : $SGYP It was tough and damning Report for $IRWD
                  • freefdawatchlist | Send Message 18 Feb

           After Hour Earnings: $RGLS, $CENX, $JWN, $IRWD, $AHS, $LHO
                      • freefdawatchlist | Send Message 18 Feb

               Earning Play for Feb 18th: $MPEL, $WAB, $VA, $EIGI, $CAB, $DNR, $AGIO, $RGLS, $CENX, $JWN, $IRWD
                          • timtrading | Send Message 17 Sep 2015

                            bullish engulfing patterns $HYG,$DRI,$MFA,$OVAS,$IRWD,$AEGR,$ZSPH,$HQY,$SRNE,$TIP
                              • wazzaofwallst | Send Message 23 Jun 2015

                                Exciting growth expectations for Ironwood Pharmaceuticals - $IRWD -
                                  • freefdawatchlist | Send Message 9 Jun 2015

                           Premarket Trading Ideas for Jun 10th: $ONVO, $AXN, $PBMD, $EROS, $FRAN, $KKD, $TLRD, $MNKD, $IRWD, $SRDL, $UWTI
                                      • Investors Prophet | Send Message 30 Apr 2015

                                        SELL ALERTS (NASDAQ Strategy) ... $BWLD $IRWD ... Prices for recent alerts:
                                          Company Description
                                          Ironwood Pharmaceuticals, Inc. is an pharmaceutical company. It discovers, develops and intends to commercialize differentiated medicines that improve patient's lives. Its products include linaclotide, a guanylate cyclase type-C agonist being developed for the treatment of patients with... More
                                          Sector: Healthcare
                                          Industry: Medical Laboratories & Research
                                          Country: United States